Single-and repeat-dose toxicity of HM10760A, a long-acting erythropoietin, in rats and monkeys.
|
| Abstract |
Anemia is a frequent complication of chronic kidney disease (CKD) that causes an increase in morbidity and mortality and accelerates the rate of disease progression. Treatment with recombinant human erythropoietin (rhEPO) is a major breakthrough in the therapy of renal anemia. HM10760A, a long-acting EPO, has been developed as a treatment for anemia in CKD patients. A series of preclinical toxicology studies, such as acute, 4 week repeat-dose, and 13 week repeat-dose, was completed to support the safety of human exposure to HM10760A for up to 13 weeks. The rodent and non-rodent species used in the pivotal preclinical general toxicity studies were rats and monkeys, respectively. A once-a-week or once-every-two-week i.v dosing regimen was applied for 4 week and 13 week repeat-dose toxicity studies, respectively, in consideration of the expected administration frequency in humans. Based on the 13 week repeat-dose toxicity studies, 2.61 μg/kg and 22.03 μg/kg can be considered as the NOAELs (no observed adverse effect levels) in rats and monkeys, respectively. Almost all observations recorded at the low- and mid-dose levels are typical pharmacological effects of EPO and not uniquely attributed HM10760A toxicity. To account for the differences between human being and animal physiologies, the safety of HM10760A needs to be further confirmed in future clinical studies.
|
|---|---|
| Authors | Hyung-Kyu Lim, Jaehyuk Choi, Daejin Kim, Sung Min Bae, Dae Kyong Kim, In Young Choi, Ha Hyung Kim |
| Journal | Toxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 402 Pg. 115126 (09 01 2020) ISSN: 1096-0333 [Electronic] United States |
| PMID | 32645313 (Publication Type: Journal Article) |
| Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!